Report Detail

Request for Sample of this report

Pharma & Healthcare Global Transforming Growth Factor Beta 1 Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM2790977
    • |
  • 30 July, 2019
    • |
  • Global
    • |
  • 123 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

Transforming growth factor beta 1 or TGF-β1 is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation, and apoptosis. In humans, TGF-β1 is encoded by the TGFB1 gene

Scope of the Report:
North America is the largest consumption place, with a consumption market share nearly 61.5% in 2017. Following North America, Asia-Pacific and Europe is the second two largest consumption places with the consumption market share of 18% and 17%, respectively.
The worldwide market for Transforming Growth Factor Beta 1 is expected to grow at a CAGR of roughly 11.3% over the next five years, will reach 1790 million US$ in 2024, from 1050 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Transforming Growth Factor Beta 1 in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Roche
Shionogi Ltd
Acceleron Pharma Inc
Genzyme Corp
Isarna Therapeutics GmbH
Scholar Rock
Sirnaomics Inc
Eli Lilly and Co
Formation Biologics Inc
Novartis AG

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Pirfenidone
Galunisertib
Others

Market Segment by Applications, can be divided into
IPF
Cancer
Others

There are 15 Chapters to deeply display the global Transforming Growth Factor Beta 1 market.
Chapter 1, to describe Transforming Growth Factor Beta 1 Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Transforming Growth Factor Beta 1, with sales, revenue, and price of Transforming Growth Factor Beta 1, in 2017 and 2018;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2017 and 2018;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Transforming Growth Factor Beta 1, for each region, from 2014 to 2019;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2014 to 2019;
Chapter 12, Transforming Growth Factor Beta 1 market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024;
Chapter 13, 14 and 15, to describe Transforming Growth Factor Beta 1 sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source


Table of Contents

    1 Market Overview

    • 1.1 Transforming Growth Factor Beta 1 Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Pirfenidone
      • 1.2.2 Galunisertib
      • 1.2.3 Others
    • 1.3 Market Analysis by Applications
      • 1.3.1 IPF
      • 1.3.2 Cancer
      • 1.3.3 Others
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Nigeria Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Roche
      • 2.1.1 Business Overview
      • 2.1.2 Transforming Growth Factor Beta 1 Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Roche Transforming Growth Factor Beta 1 Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Shionogi Ltd
      • 2.2.1 Business Overview
      • 2.2.2 Transforming Growth Factor Beta 1 Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Shionogi Ltd Transforming Growth Factor Beta 1 Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Acceleron Pharma Inc
      • 2.3.1 Business Overview
      • 2.3.2 Transforming Growth Factor Beta 1 Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Genzyme Corp
      • 2.4.1 Business Overview
      • 2.4.2 Transforming Growth Factor Beta 1 Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Genzyme Corp Transforming Growth Factor Beta 1 Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Isarna Therapeutics GmbH
      • 2.5.1 Business Overview
      • 2.5.2 Transforming Growth Factor Beta 1 Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Scholar Rock
      • 2.6.1 Business Overview
      • 2.6.2 Transforming Growth Factor Beta 1 Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Scholar Rock Transforming Growth Factor Beta 1 Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Sirnaomics Inc
      • 2.7.1 Business Overview
      • 2.7.2 Transforming Growth Factor Beta 1 Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Sirnaomics Inc Transforming Growth Factor Beta 1 Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Eli Lilly and Co
      • 2.8.1 Business Overview
      • 2.8.2 Transforming Growth Factor Beta 1 Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Formation Biologics Inc
      • 2.9.1 Business Overview
      • 2.9.2 Transforming Growth Factor Beta 1 Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Novartis AG
      • 2.10.1 Business Overview
      • 2.10.2 Transforming Growth Factor Beta 1 Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Novartis AG Transforming Growth Factor Beta 1 Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Transforming Growth Factor Beta 1 Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Transforming Growth Factor Beta 1 Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Transforming Growth Factor Beta 1 Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Transforming Growth Factor Beta 1 Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Transforming Growth Factor Beta 1 Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Transforming Growth Factor Beta 1 Market Analysis by Regions

    • 4.1 Global Transforming Growth Factor Beta 1 Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Transforming Growth Factor Beta 1 Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Transforming Growth Factor Beta 1 Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
    • 4.3 Europe Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
    • 4.5 South America Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)

    5 North America Transforming Growth Factor Beta 1 by Countries

    • 5.1 North America Transforming Growth Factor Beta 1 Sales, Revenue and Market Share by Countries
      • 5.1.1 North America Transforming Growth Factor Beta 1 Sales and Market Share by Countries (2014-2019)
      • 5.1.2 North America Transforming Growth Factor Beta 1 Revenue and Market Share by Countries (2014-2019)
    • 5.2 United States Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
    • 5.3 Canada Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)

    6 Europe Transforming Growth Factor Beta 1 by Countries

    • 6.1 Europe Transforming Growth Factor Beta 1 Sales, Revenue and Market Share by Countries
      • 6.1.1 Europe Transforming Growth Factor Beta 1 Sales and Market Share by Countries (2014-2019)
      • 6.1.2 Europe Transforming Growth Factor Beta 1 Revenue and Market Share by Countries (2014-2019)
    • 6.2 Germany Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
    • 6.3 UK Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
    • 6.4 France Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
    • 6.5 Russia Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
    • 6.6 Italy Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Transforming Growth Factor Beta 1 by Countries

    • 7.1 Asia-Pacific Transforming Growth Factor Beta 1 Sales, Revenue and Market Share by Countries
      • 7.1.1 Asia-Pacific Transforming Growth Factor Beta 1 Sales and Market Share by Countries (2014-2019)
      • 7.1.2 Asia-Pacific Transforming Growth Factor Beta 1 Revenue and Market Share by Countries (2014-2019)
    • 7.2 China Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
    • 7.3 Japan Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
    • 7.4 Korea Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
    • 7.5 India Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)

    8 South America Transforming Growth Factor Beta 1 by Countries

    • 8.1 South America Transforming Growth Factor Beta 1 Sales, Revenue and Market Share by Countries
      • 8.1.1 South America Transforming Growth Factor Beta 1 Sales and Market Share by Countries (2014-2019)
      • 8.1.2 South America Transforming Growth Factor Beta 1 Revenue and Market Share by Countries (2014-2019)
    • 8.2 Brazil Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Transforming Growth Factor Beta 1 by Countries

    • 9.1 Middle East and Africa Transforming Growth Factor Beta 1 Sales, Revenue and Market Share by Countries
      • 9.1.1 Middle East and Africa Transforming Growth Factor Beta 1 Sales and Market Share by Countries (2014-2019)
      • 9.1.2 Middle East and Africa Transforming Growth Factor Beta 1 Revenue and Market Share by Countries (2014-2019)
    • 9.2 Saudi Arabia Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
    • 9.3 UAE Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Transforming Growth Factor Beta 1 Sales and Growth Rate (2014-2019)

    10 Global Transforming Growth Factor Beta 1 Market Segment by Type

    • 10.1 Global Transforming Growth Factor Beta 1 Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Transforming Growth Factor Beta 1 Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Transforming Growth Factor Beta 1 Revenue and Market Share by Type (2014-2019)
    • 10.2 Pirfenidone Sales Growth and Price
      • 10.2.1 Global Pirfenidone Sales Growth (2014-2019)
      • 10.2.2 Global Pirfenidone Price (2014-2019)
    • 10.3 Galunisertib Sales Growth and Price
      • 10.3.1 Global Galunisertib Sales Growth (2014-2019)
      • 10.3.2 Global Galunisertib Price (2014-2019)
    • 10.4 Others Sales Growth and Price
      • 10.4.1 Global Others Sales Growth (2014-2019)
      • 10.4.2 Global Others Price (2014-2019)

    11 Global Transforming Growth Factor Beta 1 Market Segment by Application

    • 11.1 Global Transforming Growth Factor Beta 1 Sales Market Share by Application (2014-2019)
    • 11.2 IPF Sales Growth (2014-2019)
    • 11.3 Cancer Sales Growth (2014-2019)
    • 11.4 Others Sales Growth (2014-2019)

    12 Transforming Growth Factor Beta 1 Market Forecast (2019-2024)

    • 12.1 Global Transforming Growth Factor Beta 1 Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Transforming Growth Factor Beta 1 Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Transforming Growth Factor Beta 1 Market Forecast (2019-2024)
      • 12.2.2 Europe Transforming Growth Factor Beta 1 Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Transforming Growth Factor Beta 1 Market Forecast (2019-2024)
      • 12.2.4 South America Transforming Growth Factor Beta 1 Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Transforming Growth Factor Beta 1 Market Forecast (2019-2024)
    • 12.3 Transforming Growth Factor Beta 1 Market Forecast by Type (2019-2024)
      • 12.3.1 Global Transforming Growth Factor Beta 1 Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Transforming Growth Factor Beta 1 Market Share Forecast by Type (2019-2024)
    • 12.4 Transforming Growth Factor Beta 1 Market Forecast by Application (2019-2024)
      • 12.4.1 Global Transforming Growth Factor Beta 1 Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Transforming Growth Factor Beta 1 Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Transforming Growth Factor Beta 1 . Industry analysis & Market Report on Transforming Growth Factor Beta 1 is a syndicated market report, published as Global Transforming Growth Factor Beta 1 Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Transforming Growth Factor Beta 1 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,690.04
      		4,035.06
      		5,380.08
      		3,239.88
      		4,859.82
      		6,479.76
      		531,361.20
      		797,041.80
      		1,062,722.40
      		293,712.00
      		440,568.00
      		587,424.00
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo